BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37290380)

  • 1. Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches.
    Kansız S; Elçin YM
    Adv Colloid Interface Sci; 2023 Jul; 317():102930. PubMed ID: 37290380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive polymersomes for programmed drug delivery.
    Meng F; Zhong Z; Feijen J
    Biomacromolecules; 2009 Feb; 10(2):197-209. PubMed ID: 19123775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive polymersomes as nanocarriers for drug and gene delivery.
    Onaca O; Enea R; Hughes DW; Meier W
    Macromol Biosci; 2009 Feb; 9(2):129-39. PubMed ID: 19107717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-Responsive Polymersomes for Biomedical Applications.
    Hu X; Zhang Y; Xie Z; Jing X; Bellotti A; Gu Z
    Biomacromolecules; 2017 Mar; 18(3):649-673. PubMed ID: 28212005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive polymersomes for cancer therapy.
    Thambi T; Park JH; Lee DS
    Biomater Sci; 2016 Jan; 4(1):55-69. PubMed ID: 26456625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery.
    Tuguntaev RG; Okeke CI; Xu J; Li C; Wang PC; Liang XJ
    Curr Pharm Des; 2016; 22(19):2857-65. PubMed ID: 26898733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the Dilemma of Permeability and Stability of Polymersomes through Traceless Cross-Linking.
    Wang X; Hu J; Liu S
    Acc Chem Res; 2022 Dec; 55(23):3404-3416. PubMed ID: 36351034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymersome-based drug-delivery strategies for cancer therapeutics.
    Anajafi T; Mallik S
    Ther Deliv; 2015; 6(4):521-34. PubMed ID: 25996048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymersome-based protein drug delivery - quo vadis?
    Gouveia MG; Wesseler JP; Ramaekers J; Weder C; Scholten PBV; Bruns N
    Chem Soc Rev; 2023 Jan; 52(2):728-778. PubMed ID: 36537575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-Triggered Polymersome-Based Anticancer Therapeutics Delivery.
    Hernández Becerra E; Quinchia J; Castro C; Orozco J
    Nanomaterials (Basel); 2022 Mar; 12(5):. PubMed ID: 35269324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Polymersomes for Diagnostics and Therapy.
    Leong J; Teo JY; Aakalu VK; Yang YY; Kong H
    Adv Healthc Mater; 2018 Apr; 7(8):e1701276. PubMed ID: 29334183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advancement of Polymersomes as Drug Delivery Carrier.
    Singh K; Biharee A; Vyas A; Thareja S; Jain AK
    Curr Pharm Des; 2022; 28(20):1621-1631. PubMed ID: 35418282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging era of "somes": polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy.
    Sharma AK; Prasher P; Aljabali AA; Mishra V; Gandhi H; Kumar S; Mutalik S; Chellappan DK; Tambuwala MM; Dua K; Kapoor DN
    Drug Deliv Transl Res; 2020 Oct; 10(5):1171-1190. PubMed ID: 32504410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical stimuli-responsive liposomes and polymersomes as drug delivery vehicles based on phase transitions in the membrane.
    Deng Y; Ling J; Li MH
    Nanoscale; 2018 Apr; 10(15):6781-6800. PubMed ID: 29616274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Intracellular Delivery Nanocarriers and Nanoreactors from Oxidation-Responsive Polymersomes via Synchronized Bilayer Cross-Linking and Permeabilizing Inside Live Cells.
    Deng Z; Qian Y; Yu Y; Liu G; Hu J; Zhang G; Liu S
    J Am Chem Soc; 2016 Aug; 138(33):10452-66. PubMed ID: 27485779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes.
    Kauscher U; Holme MN; Björnmalm M; Stevens MM
    Adv Drug Deliv Rev; 2019 Jan; 138():259-275. PubMed ID: 30947810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward enzyme-responsive polymersome drug delivery.
    Paruchuri BC; Gopal V; Sarupria S; Larsen J
    Nanomedicine (Lond); 2021 Dec; 16(30):2679-2693. PubMed ID: 34870451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymersome carriers: from self-assembly to siRNA and protein therapeutics.
    Christian DA; Cai S; Bowen DM; Kim Y; Pajerowski JD; Discher DE
    Eur J Pharm Biopharm; 2009 Mar; 71(3):463-74. PubMed ID: 18977437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in formation, properties, and applications of polymersomes.
    Liao J; Wang C; Wang Y; Luo F; Qian Z
    Curr Pharm Des; 2012; 18(23):3432-41. PubMed ID: 22632981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.